Evidence map›Paper›PMID 38395806›Full record

ArticleBMC nephrology2024

Assessing the effects of tempol on renal fibrosis, inflammation, and oxidative stress in a high-salt diet combined with 5/6 nephrectomy rat model: utilizing oxidized albumin as a biomarker.

Beibei Liu, Yanling Hu, Danyang Tian, Jianlong Dong, Bing-Feng Li

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Tempol Protects Against Radiation Injury in the Submandibular Gland Through the β-Catenin Signaling Pathway.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Beibei LiuCollege of Life and Health, Nanjing Polytechnic Institute, No.188 Xinle Road, Luhe District, 210048, Nanjing, Nanjing, Jiangsu, China.
Yanling HuCollege of Life and Health, Nanjing Polytechnic Institute, No.188 Xinle Road, Luhe District, 210048, Nanjing, Nanjing, Jiangsu, China.
Danyang TianDepartment of Physiology, Hebei Medical University, Shijiazhuang, China.
Jianlong DongHebei University of Chinese Medicine, The First Affiliated Hospital, Shijiazhuang, China.
Bing-Feng LiCollege of Life and Health, Nanjing Polytechnic Institute, No.188 Xinle Road, Luhe District, 210048, Nanjing, Nanjing, Jiangsu, China. 13814021850@139.com.
Nanjing Polytechnic Institute · CNHebei Medical University · CNHebei University of Chinese Medicine · CN

Funding

College Students' Innovative Entrepreneurial Training Plan Program of 2023, Education Department of Jiangsu Province No.1122Nanjing Polytechnic Institute scientific research project NJPI-RC-2022-06the Natural Science Foundation of Jiangsu Province BK20230117
6 · The paper itself

Abstract

backgroundOxidative stress has been implicated in the pathogenesis of chronic kidney disease (CKD), prompting the exploration of antioxidants as a potential therapeutic avenue for mitigating disease progression. This study aims to investigate the beneficial impact of Tempol on the progression of CKD in a rat model utilizing oxidized albumin as a biomarker.

methodsAfter four weeks of treatment, metabolic parameters, including body weight, left ventricle residual weight, kidney weight, urine volume, and water and food intake, were measured. Systolic blood pressure, urinary protein, oxidized albumin level, serum creatinine (Scr), blood urea nitrogen (BUN), 8-OHdG, TGF-β1, and micro-albumin were also assessed. Renal fibrosis was evaluated through histological and biochemical assays. P65-NF-κB was quantified using an immunofluorescence test, while Smad3, P65-NF-κB, and Collagen I were measured using western blot. TNF-α, IL-6, MCP-1, TGF-β1, Smad3, and P65-NF-κB were analyzed by RT-qPCR.

resultsRats in the high-salt diet group exhibited impaired renal function, characterized by elevated levels of blood urea nitrogen, serum creatinine, 8-OHdG, urine albumin, and tubulointerstitial damage, along with reduced body weight. However, these effects were significantly ameliorated by Tempol administration. In the high-salt diet group, blood pressure, urinary protein, and oxidized albumin levels were notably higher compared to the normal diet group, but Tempol administration in the treatment group reversed these effects. Rats in the high-salt diet group also displayed increased levels of proinflammatory factors (TNF-α, IL-6, MCP1) and profibrotic factors (NF-κB activation, Collagen I), elevated expression of NADPH oxidation-related subunits (P65), and activation of the TGF-β1/Smad3 signaling pathway. Tempol treatment inhibited NF-κB-mediated inflammation and TGF-β1/Smad3-induced renal fibrosis signaling pathway activation.

conclusionThese findings suggest that Tempol may hold therapeutic potential for preventing and treating rats undergoing 5/6 nephrectomy. Further research is warranted to elucidate the mechanisms underlying Tempol's protective effects and its potential clinical applications. Besides, there is a discernible positive relationship between oxidized albumin and other biomarkers, such as 8-OHG, urinary protein levels, mALB, Scr, BUN, and TGF-β1 in a High-salt diet combined with 5/6 nephrectomy rat model. These findings suggest the potential utility of oxidized albumin as a sensitive indicator for oxidative stress assessment.

Indexed as

Cyclic N-OxidesRenal Insufficiency, ChronicSpin LabelsTransforming Growth Factor beta1AlbuminsAnimalsBiomarkersBody WeightCollagenCreatinineDietFibrosisInflammationInterleukin-6NephrectomyNF-kappa BAlbuminsBiomarkersCollagenCreatinineCyclic N-OxidesInterleukin-6NF-kappa BSodium ChlorideSodium, DietarySpin LabelstempolTransforming Growth Factor beta1Tumor Necrosis Factor-alpha5/6 nephrectomyChronic kidney diseaseOxidative stressOxidized albuminTempol

Identifiers

PMID38395806
PMCPMC10893674
OpenAlexW4392094777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.